Inscopix

13 articles with Inscopix

• Inscopix Launches nVisionTM System for Synchronized Acquisition of Behavioral Movies with In Vivo Miniscope Data

  11/10/2022

  Inscopix, Inc. announced the official release of Inscopix’s new multimodal behavioral technology called the nVision System, at Neuroscience 2022 being held in San Diego, California, November 12-16.

• Bruker Announces Acquisition of Inscopix for Neuroscience Research

  11/8/2022

  Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Inscopix, Inc., a neuroscience pioneer and market leader of miniaturized microscopes, known as miniscopes, for freely moving animal brain imaging.

• Inscopix Expands Cloud-Based IDEAS Platform for Individual Lab Use

  11/2/2022

  Inscopix, Inc. announced that it is expanding the market availability for its Inscopix Data Exploration, Analysis and Sharing Platform to include individual labs, which allows academic researchers to vastly improve how they share, analyze and organize neuroscience data.

• Inscopix CEO Kunal Ghosh, PhD Named to PharmaVoice 100

  9/7/2022

  Inscopix, Inc. announced that Kunal Ghosh, PhD, Chief Executive Officer of Inscopix, has been named to the PharmaVoice 100 — an annual list that recognizes the most inspiring people in the life-sciences industry.

• Inscopix Announces Cloud-Based IDEAS™ Platform for Neuroscience Research with New Neural Circuit Workflow

  7/7/2022

  Inscopix, Inc. announced that it is launching the Inscopix Data Exploration, Analysis and Sharing (IDEAS) Platform to help neuroscience research groups improve how they analyze and organize neuroscience data.

• Inscopix Launches New Integrated Miniscope-Behavioral Platform and Co-marketing Collaboration with Noldus

  6/27/2022

  New nVision ™ Platform enables neuroscience researchers to synchronously acquire behavioral videos with in vivo miniscope images.

• Inscopix Expands Strategic Partnership with GRINTECH to Become Exclusive Global Supplier of GRIN lenses

  6/15/2022

  The new relationship covers all non-human neuroscience research applications, including one- and multi- photon imaging.

• Inscopix Expands Applications with Blood Flow Imaging to Study Relationship between Brain Activity and Vascular Dynamics

  3/8/2022

  Inscopix, Inc. announced that it has launched a new application for its miniscope-based platforms to investigate neuronal activity and blood flow simultaneously, a novel research method that may prove critical to studying neurovascular dynamics in the context of aging, dementia, stroke and other debilitating diseases.

• Inscopix’s nVue System for Brain Mapping Named Innovation of the Year by The Scientist

  12/7/2021

  Inscopix, Inc., a neuroscience company helping decode the brain for tomorrow’s treatments, announced that its dual color miniscope imaging technology, the nVue™ System, has been named the top innovation for 2021 by The Scientist Magazine based on an independent review from a team of esteemed judges.

• Inscopix and NeuroNexus to Collaborate on Integrated Brain Electrophysiology and Imaging Device

  11/9/2021

  Inscopix and NeuroNexus to Collaborate on Integrated Brain Electrophysiology and Imaging Device

• Inscopix Showcases New Brain Mapping Technology and Key Scientific Presentations at the 50th Annual Meeting of the Society for Neuroscience

  11/8/2021

  Inscopix Showcases New Brain Mapping Technology and Key Scientific Presentations at the 50th Annual Meeting of the Society for Neuroscience

• Inscopix Names Pharma Leader Dr. David Gray as Chief Scientific Officer in New Position to Oversee Drug Development for Brain Disorders

  10/28/2021

  Inscopix, Inc. today announced it appointed David Gray, Ph.D., as Chief Scientific Officer (CSO)

• Inscopix Appoints Martin Verhoef as Chief Commercial Officer

  4/1/2021

  Inscopix Inc., a leading neurotechnology company in California that empowers breakthroughs in brain science, announced today that Martin Verhoef has joined the company as Chief Commercial Officer. As a key member of Inscopix’s executive leadership team, Mr. Verhoef will lead all commercial operations, spanning strategy, sales, marketing, business development and customer success.